Tanvir Ahmed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tanvir Ahmed has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Kazi Tasnuva Alam
North South University
6 shared publications - Zarin Tasnim Tisha
University of Surrey
4 shared publications Arpana Parihar
CSIR-Advanced Materials and Processes Research Institute, India
1 shared publication- Charlotte Haigh
Department of Chemical Engineering, Loughborough University, Epinal Way, Loughborough LE11 3TU, UK
1 shared publication - Diganta Bhusan Das
Chemical Engineering Department, Loughborough University, Loughborough LE11 3TU, UK
1 shared publication - Jasim Uddin
Universiti Malaya
1 shared publication
Latest Publications
- 2 July 2026
- Published by Springer Nature
- p. 139-195
Diagnostic Nanoprobes and Imaging Agents
- 2 July 2026
- Published by Springer Nature
- p. 197-249
Nanomaterials for Regenerative Medicine
- 28 February 2026
- Published by Elsevier in Progress in Biophysics and Molecular Biology
- Vol. 200, 6-18
Developing artificial cytoskeletons using RNA origami-based nanotubes
- 28 February 2026
- Published by Elsevier in Progress in Biophysics and Molecular Biology
- Vol. 200, 6-18
Developing artificial cytoskeletons using RNA origami-based nanotubes
- 29 January 2026
- Published by Springer Nature
- p. 177-214
Effect of Original Reinforcement and Surface Functionalization on Properties
- 29 January 2026
- Published by Springer Nature
- p. 177-214
Effect of Original Reinforcement and Surface Functionalization on Properties
- 22 January 2026
- Published by Springer Nature
- p. 149-179
miRNA Modulation of Cancer Therapeutic Resistance Due to Failed Autophagy and Cancer Stemness
- 22 January 2026
- Published by Springer Nature
- p. 149-179
miRNA Modulation of Cancer Therapeutic Resistance Due to Failed Autophagy and Cancer Stemness
- 20 January 2026
- Published by Taylor & Francis
- p. 304-343
Intelligent Responsive Nanoplatforms in Theragnostics
Through the integration of therapeutic and diagnostic functions into a single nanoscale system, intelligent responsive nanoplatforms have completely transformed the field of theragnostics. These nanoplatforms use both external and internal stimuli, including pH, temperature, redox potential, light, and enzyme activity, to facilitate targeted drug delivery, real-time imaging, and on-demand therapeutic activation. By adapting to physiological changes, they increase treatment accuracy, reduce systemic toxicity, and enhance patient outcomes. This chapter looks at the essential design principles of intelligent nanoplatforms, emphasizing significant nanomaterials, including stimuli-responsive polymers, biomimetic nanoparticles, and multifunctional hybrid structures. It includes the role of emerging technologies, such as artificial intelligence and machine learning, in the optimization of nanotheragnostic applications. The chapter also discusses significant challenges such as biocompatibility, large-scale production, and regulatory obstacles that must be addressed for effective clinical translation. This chapter offers a detailed examination of recent advancements and future directions, highlighting the transformative potential of intelligent responsive nanoplatforms in personalized medicine. The ability to concurrently diagnose and treat diseases, especially in areas such as of cancer therapy, infectious diseases, and neurological disorders, places them at the leading edge of next-generation nanomedicine. Ongoing advancements in research and development indicate that these smart nanoplatforms will transform precision healthcare by providing innovative solutions to complex medical challenges.
- 20 January 2026
- Published by Taylor & Francis
- p. 304-343
Intelligent Responsive Nanoplatforms in Theragnostics
Through the integration of therapeutic and diagnostic functions into a single nanoscale system, intelligent responsive nanoplatforms have completely transformed the field of theragnostics. These nanoplatforms use both external and internal stimuli, including pH, temperature, redox potential, light, and enzyme activity, to facilitate targeted drug delivery, real-time imaging, and on-demand therapeutic activation. By adapting to physiological changes, they increase treatment accuracy, reduce systemic toxicity, and enhance patient outcomes. This chapter looks at the essential design principles of intelligent nanoplatforms, emphasizing significant nanomaterials, including stimuli-responsive polymers, biomimetic nanoparticles, and multifunctional hybrid structures. It includes the role of emerging technologies, such as artificial intelligence and machine learning, in the optimization of nanotheragnostic applications. The chapter also discusses significant challenges such as biocompatibility, large-scale production, and regulatory obstacles that must be addressed for effective clinical translation. This chapter offers a detailed examination of recent advancements and future directions, highlighting the transformative potential of intelligent responsive nanoplatforms in personalized medicine. The ability to concurrently diagnose and treat diseases, especially in areas such as of cancer therapy, infectious diseases, and neurological disorders, places them at the leading edge of next-generation nanomedicine. Ongoing advancements in research and development indicate that these smart nanoplatforms will transform precision healthcare by providing innovative solutions to complex medical challenges.
- 25 August 2025
- Published by Springer Nature
- p. 141-191
Controlled Release of Drugs from Nanocomposites Composed of Layered Double Hydroxides (LDHs) and Polylactic Acid (PLA)
- 25 August 2025
- Published by Springer Nature
- p. 141-191
Controlled Release of Drugs from Nanocomposites Composed of Layered Double Hydroxides (LDHs) and Polylactic Acid (PLA)
- 10 May 2025
- Published by Springer Nature
- p. 227-261
Nanoparticles Enhancing Efficacy in Drug Formulation and Drug Delivery
- 10 May 2025
- Published by Springer Nature
- p. 227-261
Nanoparticles Enhancing Efficacy in Drug Formulation and Drug Delivery
- Open Access
- 19 March 2025
- Published by Wiley in Medcomm – Biomaterials and Applications
- Vol. 4 (1)
Cardiac Tissue Engineering Using Stimuli‐Responsive Biomaterials for the Targeted Therapy of Myocardial Infarction
Cardiac tissue engineering presents a viable strategy for the targeted therapy of myocardial infarction (MI), overcoming the limitations of existing therapies in cardiac repair and regeneration. This review explores the potential of stimuli‐responsive biomaterials that engage with the cardiac environment by reacting to various environmental stimuli including pH, temperature, enzymes, ultrasound, and reactive oxygen species. These materials enable precise drug delivery, modulate cellular responses, and enhance tissue regeneration. Biomaterials such as hydrogels, polymers, chitosan, collagen, and alginate improve the accuracy and effectiveness of targeted and localized delivery of drugs, stem cells, and growth factors, thus improving the precision and efficacy of treatments. The review looks at the ability of these biomaterials to mimic the complex biochemical and mechanical cues of a healthy myocardium. The challenges and prospects of clinical applications for stimuli‐responsive biomaterials are discussed, highlighting their transformative potential in targeted cardiac therapy while improving outcomes for patients with MI.
- 19 March 2025
- Published by Wiley in Medcomm – Biomaterials and Applications
- Vol. 4 (1)
Open AccessCardiac Tissue Engineering Using Stimuli‐Responsive Biomaterials for the Targeted Therapy of Myocardial Infarction
Cardiac tissue engineering presents a viable strategy for the targeted therapy of myocardial infarction (MI), overcoming the limitations of existing therapies in cardiac repair and regeneration. This review explores the potential of stimuli‐responsive biomaterials that engage with the cardiac environment by reacting to various environmental stimuli including pH, temperature, enzymes, ultrasound, and reactive oxygen species. These materials enable precise drug delivery, modulate cellular responses, and enhance tissue regeneration. Biomaterials such as hydrogels, polymers, chitosan, collagen, and alginate improve the accuracy and effectiveness of targeted and localized delivery of drugs, stem cells, and growth factors, thus improving the precision and efficacy of treatments. The review looks at the ability of these biomaterials to mimic the complex biochemical and mechanical cues of a healthy myocardium. The challenges and prospects of clinical applications for stimuli‐responsive biomaterials are discussed, highlighting their transformative potential in targeted cardiac therapy while improving outcomes for patients with MI.
- 12 March 2025
- Published by Springer Nature
- p. 185-211
Glycemic Control and Insulin Management: The Role of AI in Glycemic Index Control and Insulin Regulation
- 12 March 2025
- Published by Springer Nature
- p. 185-211
Glycemic Control and Insulin Management: The Role of AI in Glycemic Index Control and Insulin Regulation